The Journal of Nuclear Medicine (JNM)—self-published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI), a nonprofit, international scientific and professional organization—offers readers around the globe clinical and basic science investigations, continuing education articles, state-of-the-art reviews, employment opportunities, and updates on rapidly changing issues in practice and research.
According to the 2023 Journal Citation Reports (released in June 2024), JNM ranks sixth in impact among 204 medical journals worldwide in the radiology, nuclear medicine and medical imaging category.
- Impact factor – 9.1
- Five-year impact factor – 9.1
- Immediacy index – 2.6
- Total citations – 29,679
- Eigenfactor Score – 0.02795
- Article Influence Score – 2.606
The Journal of Nuclear Medicine is available online at http://jnm.snmjournals.org. A 2025 online subscription to the journal includes full access to archives, complete issue PDFs, open access and online ahead of print articles. For subscription rates, click here.
Print copies are available for purchase at $60 per copy. To order a copy, contact the SNMMI Subscription Services at subscriptions@snmmi.org or telephone 1-800-513-6853.
The ideas and opinions expressed in JNM do not necessarily reflect those of the SNMMI or the Editors of JNM unless so stated. Publication of an advertisement or other product mentioned in JNM should not be construed as an endorsement of the product or the manufacturer's claims. Readers are encouraged to contact the manufacturer with any questions about the features or limitations of the products mentioned. The SNMMI does not assume any responsibility for any injury or damage to persons or property arising from or related to any use of the material contained in this journal. The reader is advised to check the appropriate medical literature and the product information currently provided by the manufacturer of each drug to be administered to verify the dosage, the method and duration of administration, and contraindications.